SAN DIEGO, Oct. 8, 2013 /PRNewswire/ -- Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, today announced that Gartner, Inc., the leading provider of research and analysis on the global information technology industry, has rated the company "very high" in a recent report[1] on Electronic Laboratory Notebook (ELN) vendors. Accelrys was the only vendor to achieve the highest possible rating of "very high" in all five categories of new product development (NPD) – concept, research, development, transfer and manufacturing – and was among only four ELN vendors of 23 to also offer a Laboratory Information Management System (LIMS) solution.
(Logo: http://photos.prnewswire.com/prnh/20120416/MM88629LOGO)
The report is based on insights collected by Gartner throughout hundreds of interviews, briefings and interactions with various clients.
According to Gartner research director Michael Shanler, "Leaders with ERP and product life cycle management (PLM) experience are asking how difficult it is to move toward developing end-to-end scientific insights to better support the entire spectrum from earlier-stage concept development through late-stage manufacturing. This allure of end-to-end informatics is very attractive, but entering this space requires IT organizations to rethink their approach towards laboratory-centric activities."
"Accelrys software solutions cover the entire product lifecycle for organizations that rely on science to innovate in their products and processes," said Accelrys President and CEO Max Carnecchia. "We believe Accelrys' very high ratings in Gartner's recent report confirm our industry-leading ability to advance predictive, sustainable innovation across the industries we serve."
Access the full Gartner report: Product Innovation Requires Laboratory Informatics Systems to Transcend Phases.
About Accelrys, Inc.
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, supports industries and organizations that rely on scientific innovation to differentiate themselves. The industry-leading Accelrys Enterprise Platform provides a broad and flexible scientific solution optimized to integrate the diversity of science, experimental processes and information requirements across the research, development, process scale-up and early manufacturing phases of product development. By incorporating capabilities in applications for modeling and simulation, enterprise lab management, workflow and automation, and data management and informatics, Accelrys enables scientific innovators to access, organize, analyze and share data in unprecedented ways, ultimately enhancing innovation, improving productivity and compliance, reducing costs and speeding time from lab to market.
Accelrys solutions are used by more than 1,300 companies in the pharmaceutical, biotechnology, energy, chemicals, aerospace, consumer packaged goods and industrial products industries. Headquartered in San Diego, California, USA, Accelrys employs more than 200 full-time PhD scientists. For more information about Accelrys, visit www.accelrys.com.
Disclaimer:
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
[1] Gartner, "Product Innovation Requires Laboratory Informatics Systems to Transcend Phases," by Michael Shanler, September 26, 2013.
Related Links
- Access the Gartner report
- Learn more about Accelrys ELN
- Learn more about Accelrys LIMS
- Learn more about Contur ELN
- Accelrys Website
- Follow Accelrys on Twitter
- Friend Accelrys on Facebook
- Accelrys' YouTube Channel
- Connect with Accelrys on LinkedIn
SOURCE Accelrys, Inc.